Dr. Doriano Fabbro

Swiss Rockets Serbia Signs Joint Declaration of Intent with European Commission and Development Agency of Serbia to Establish Regional Centre of Excellence for Precision Medicine

Swiss Rockets Signs Strategic Exclusive Licensing Agreement with MGI and Complete Genomics, Subject to MGI Shareholder Approval

Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study